SJS Investment Consulting’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
SJS Investment Consulting's ABBV Position: Q3 2026 in Review
SJS Investment Consulting increased its AbbVie (ABBV) stake by 2.6% in Q3 2026, buying an estimated $12.8K and bringing the position to 1,993 shares worth $521K. The position accounts for 0.05% of the portfolio, ranked #92.
SJS Investment Consulting first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $523K in Q1 2025. 4,280 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- SJS Investment Consulting held 1,993 shares of AbbVie worth $521K as of Q3 2026.
- SJS Investment Consulting bought 50 AbbVie shares in Q3 2026, an estimated $12.8K.
- AbbVie made up 0.05% of SJS Investment Consulting's portfolio in Q3 2026, its #92 holding.
- SJS Investment Consulting first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- SJS Investment Consulting's AbbVie position peaked at $523K in Q1 2025.
- 4,280 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.